Featured News
Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington’s Disease Franchise
– Proprietary siRNA platforms, designed to enable robust and durable gene silencing throughout the brain, support a differentiated Huntington’s disease…
